Public health messages often emphasize limiting sun exposure and using sunscreen to reduce skin cancer risk. While overexposure and sunburn do increase the risk of skin cancer, limited and moderate sun exposure may also confer health benefits. Sunlight exposure is the primary natural source of vitamin D, a hormone involved in immune regulation and cellular growth control.
A study published in Anticancer Research (July–August 2006) reported that exposure to ultraviolet B (UVB) radiation was associated with a reduced risk of several types of cancer. The authors noted that UVB exposure increases endogenous vitamin D production, and vitamin D has been shown in experimental and observational research to influence cancer-related pathways, including inhibition of tumor blood supply and reduced metastatic potential.
The lead author, William Grant, suggested that both moderate sun exposure and vitamin D supplementation could be reasonable strategies to support vitamin D status. He proposed daily supplementation in the range of 1,000–1,500 IU, along with modest sun exposure (for example, about 15 minutes several times per week for fair-skinned individuals, with longer exposure needed for darker skin). These recommendations, however, remain an area of debate.
Not all research has supported vitamin D supplementation as a cancer-preventive strategy. A study published in the New England Journal of Medicine (2006; Volume 354:684–696) did not find a significant cancer-prevention benefit from vitamin D supplementation. Dr. Grant and others have pointed out that the study used a relatively low dose of vitamin D (400 IU per day), which may have been insufficient to meaningfully affect vitamin D status.
Overall, the evidence suggests a complex relationship between sun exposure, vitamin D, and cancer risk. While excessive sun exposure is clearly harmful, limited exposure and adequate vitamin D status may play a role in broader health outcomes—an area that continues to be actively researched.
